← Eichor
Condition: Oral Squamous Cell Carcinoma Oscc Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral Squamous Cell Carcinoma Oscc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Phase 3 · 1 location(s) · Qunxing Li,MD · NCT07371611Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Phase 2 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT02290145A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPS
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT07133958Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT03975322Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT06097468Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous
Phase N/A · 2 location(s) · Zhujiang Hospital · NCT07686575Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread
NA · 1 location(s) · Kolhapur Cancer Centre - Cancer Centers of America · NCT07726199Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
NA · 1 location(s) · Huashan Hospital · NCT06623266Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Phase 2/Phase 3 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT05125055Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Phase 2 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT05069857Validity of Viome's Oral/throat Cancer Test
Phase N/A · 2 location(s) · Viome · NCT06174428
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.